抗生素 SL3810 氨苄青霉素储存液(100mg/mL)=Amp SL3820 卡那霉素储存液(100mg/mL)=Kan SL3840 硫酸链霉素储存液(50mg/mL)=Sm 规格 1mL 1mL×3 1mL×10 第1页共2页 COOLABER SCIENCE & TECHNOLOGY Co.,LTD www.coolaber.com Phone: 400-878-6800 使用方法: 1.配置固体培养基 1L:请在 697 mL ...
- IOP Publishing Ltd 被引量: 0发表: 2024年 Multiorbital Nature of Doped Sr_2IrO_4 The low-energy j_(eff) = 1/2 band of Sr_2IrO_4 bears stark resemblances with the x~2 - y~2 band of La_2CuO_4, and yet no superconductivity has been found so far by doping Sr_2IrO_4. ...
ABB enduser:TAIYUAN IRON & STEEL (GROUP) CO.,LTD http://www.tisco。。com.cn/ CHINA Steidle S120014-STEIDLE-PUMP MOLULE-/4,1DF-Alu LEMO FGL.1K.303.CLLC30 Oil Control 05420103043500A systec Controls DEX4300-251-2LBLA00/SD DC 24V 0.5 DN250 PN10 316L,IP67 Herion S10G71G0032093C0;P...
Whole slide images were scanned using the TissueFAXS SL system (7.1.120; Tissue Gnostics, Vienna, Austria). Digital images were analyzed using the HALO™ software (v 3.5). Immune cell densities were assessed as positively stained cell counts per mm2. The cell density was calculated in total...
Sarclisa (isatuximab) [package insert], Sanofi Co., Ltd, Nishi Shinjuku, Tokyo (2021) Google Scholar 7 Tecentriq (atezolizumab) [prescribing information]; 2021. Available at https://www.gene.com/download/pdf/tecentriq_prescribing.pdf. Accessed April 6, 2021 Google Scholar 8 M. Attal, P.G...
ABB enduser:TAIYUAN IRON & STEEL (GROUP) CO.,LTD http://www.tisco。。com.cn/ CHINA Steidle S120014-STEIDLE-PUMP MOLULE-/4,1DF-Alu LEMO FGL.1K.303.CLLC30 Oil Control 05420103043500A systec Controls DEX4300-251-2LBLA00/SD DC 24V 0.5 DN250 PN10 316L,IP67 Herion S10G71G0032093C0;P...
typing,Monosaccharide biosynthesis pathways * Correspondence: marisa@lncc.br 1 Laboratório Nacional de Computação Científica (LNCC), Petrópolis, Rio de Janeiro, Brazil Full list of author information is available at the end of the article © 2012 Ramos et al.; licensee BioMed Central Ltd....
MCB UP LtdStrategy & LeadershipLangowitz, N.S., and Wheelwright, S.C. "Plus Development Corporation (A)" and "Plus Development Corporation (B)," cases 687-001 and 689-073. Harvard Business School, Boston 1986.Langowitz, Nan S., 1989, Plus Development Corporation (A), Harvard Business ...
Background and objectives The National Institute for Health and Care Excellence (England’s health technology assessment body) recommend the use of the average treatment effect (ATE) as an estimand for economic evaluations. However there is limited literature on methods to estimate the ATE, particular...
Lheureux S, Matei DE, Konstantinopoulos PA, Wang BX, Gadalla R, Block MS, Jewell A, Gaillard SL, McHale M, McCourt C, et al. Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer. J Immunother Cancer....